113 related articles for article (PubMed ID: 38599542)
1. The CREB1/WNK1 axis promotes the tumorigenesis of ovarian cancer via regulating HIF-1.
Ma Y; Zong H; Pan P; Shang H; Yang X
Exp Cell Res; 2024 May; 438(1):114006. PubMed ID: 38599542
[TBL] [Abstract][Full Text] [Related]
2. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
3. Bufalin inhibits ovarian carcinoma via targeting mTOR/HIF-α pathway.
Su S; Dou H; Wang Z; Zhang Q
Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):224-233. PubMed ID: 32905663
[TBL] [Abstract][Full Text] [Related]
4. IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells.
Xu S; Yu C; Ma X; Li Y; Shen Y; Chen Y; Huang S; Zhang T; Deng W; Wang Y
Eur J Pharmacol; 2021 Mar; 894():173817. PubMed ID: 33345849
[TBL] [Abstract][Full Text] [Related]
5. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
Zhang X; Qi Z; Yin H; Yang G
Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
[TBL] [Abstract][Full Text] [Related]
6. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
Zhou Y; Liu T; Wu Q; Wang H; Sun Y
Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
[TBL] [Abstract][Full Text] [Related]
8. miR-125b-5p upregulation by TRIM28 induces cisplatin resistance in non-small cell lung cancer through CREB1 inhibition.
Tan Q; Ma J; Zhang H; Wu X; Li Q; Zuo X; Jiang Y; Liu H; Yan L
BMC Pulm Med; 2022 Dec; 22(1):469. PubMed ID: 36476351
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine Regulates Proliferation, Apoptosis, Migration, and Invasion in Ovarian Cancer Cells via MiR-155-HIF-1α Axis.
Zheng L; Jia R; Zhao J
Med Sci Monit; 2019 Dec; 25():10164-10172. PubMed ID: 31887107
[TBL] [Abstract][Full Text] [Related]
10. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
11. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α.
Ao Q; Su W; Guo S; Cai L; Huang L
Sci Rep; 2015 Nov; 5():16396. PubMed ID: 26548925
[TBL] [Abstract][Full Text] [Related]
12. HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4.
Yu M; Ozaki T; Sun D; Xing H; Wei B; An J; Yang J; Gao Y; Liu S; Kong C; Zhu Y
J Exp Clin Cancer Res; 2020 Jun; 39(1):108. PubMed ID: 32522234
[TBL] [Abstract][Full Text] [Related]
13. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
Chen L; Liu T; Zhang S; Zhou J; Wang Y; Di W
J Ovarian Res; 2014 Dec; 7():115. PubMed ID: 25491408
[TBL] [Abstract][Full Text] [Related]
14. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1α degradation.
Chen Y; Liu L; Xia L; Wu N; Wang Y; Li H; Chen X; Zhang X; Liu Z; Zhu M; Liao Q; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):44. PubMed ID: 35101076
[TBL] [Abstract][Full Text] [Related]
15. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
[TBL] [Abstract][Full Text] [Related]
17. HVEM/HIF-1α promoted proliferation and inhibited apoptosis of ovarian cancer cells under hypoxic microenvironment conditions.
Duan L; Tao J; Yang X; Ye L; Wu Y; He Q; Duan Y; Chen L; Zhu J
J Ovarian Res; 2020 Apr; 13(1):40. PubMed ID: 32312328
[TBL] [Abstract][Full Text] [Related]
18. CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis.
Tong L; Wang Y; Ao Y; Sun X
Biomed Pharmacother; 2019 Jul; 115():108891. PubMed ID: 31082772
[TBL] [Abstract][Full Text] [Related]
19. IGF2-AS knockdown inhibits glycolysis and accelerates apoptosis of gastric cancer cells through targeting miR-195/CREB1 axis.
Yan B; Ren Z; Sun J; Ding C; Yang D
Biomed Pharmacother; 2020 Oct; 130():110600. PubMed ID: 34321174
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DQ786243 interacts with miR-506 and promotes progression of ovarian cancer through targeting cAMP responsive element binding protein 1.
Yan H; Silva MA; Li H; Zhu L; Li P; Li X; Wang X; Gao J; Wang P; Zhang Z
J Cell Biochem; 2018 Dec; 119(12):9764-9780. PubMed ID: 30105876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]